Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hoth Therapeutics

0.8990
+0.04805.64%
Pre-market: 0.91000.0110+1.22%08:41 EDT
Volume:121.11K
Turnover:105.01K
Market Cap:11.84M
PE:-0.70
High:0.9100
Open:0.8500
Low:0.8267
Close:0.8510
Loading ...

Hoth Therapeutics Announces Granted Japanese Patent for Novel RNA-Based Cancer Therapy Targeting KIT Gene - Expands Global IP in Precision Oncology Platform

PR Newswire
·
17 Apr

Hoth Therapeutics Is Maintained at Buy by D. Boral Capital

Dow Jones
·
15 Apr

BRIEF-Hoth Therapeutics Announces Positive Initial Data In Phase 2A Clinical Trial

Reuters
·
15 Apr

Hoth Therapeutics Announces Positive Initial Data in Phase 2a Clinical Trial

THOMSON REUTERS
·
15 Apr

Hoth Therapeutics Inc - Patients Experienced a 50% Reduction in Pruritus Severity, With Mean Scores Dropping From 1.6 on Day 1 to 0.8 by Day 21

THOMSON REUTERS
·
15 Apr

Hoth Therapeutics Inc - Ht-001 Was Well Tolerated, With No Treatment-Related Serious Adverse Events Reported

THOMSON REUTERS
·
15 Apr

Hoth Therapeutics Announces Positive Initial Data in Phase 2a Clinical Trial

PR Newswire
·
15 Apr

Hoth Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
03 Apr

Hoth Therapeutics Collaborates with Washington University on NIH Grant Application Advancing Alzheimer's Program Using NK-1 Receptor Antagonist HT-ALZ

PR Newswire
·
02 Apr

Hoth Therapeutics reports data from its Alzheimer’s candidate HT-ALZ

TIPRANKS
·
02 Apr

BRIEF-Hoth Therapeutics Plans To Advance HT-ALZ Into Clinical Development

Reuters
·
02 Apr

Hoth Therapeutics Announces Positive Pre Clinical Data Ht-Alz Shows Promising Breakthrough in Alzheimer's Disease Research Acute Treatment With Ht-Alz Led to a Rapid (~15%) Reduction in Brain Interstitial Fluid aΒ Levels, Within 20 Hours

THOMSON REUTERS
·
02 Apr

Hoth Therapeutics - Plans to Advance Ht-Alz Into Clinical Development

THOMSON REUTERS
·
02 Apr

BRIEF-Hoth Therapeutics Receives Uspto Filing Receipt For Ht-001 Formulation Patent Application, Expanding Existing Patent Coverage

Reuters
·
01 Apr

Hoth Therapeutics Receives Uspto Filing Receipt for Ht-001 Formulation Patent Application, Expanding Existing Patent Coverage

THOMSON REUTERS
·
01 Apr

Hoth Therapeutics Receives USPTO Filing Receipt for HT-001 Formulation Patent Application, Expanding Existing Patent Coverage

PR Newswire
·
01 Apr

Hoth Therapeutics Is Maintained at Buy by D. Boral Capital

Dow Jones
·
31 Mar

Hoth Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
29 Mar

Hoth Therapeutics Inc - Files Amended Patent Claims for Ht-Kit Technology

THOMSON REUTERS
·
26 Mar

Hoth Therapeutics Inc - Initiates 4-Week Toxicity Study for Ht-Kit

THOMSON REUTERS
·
26 Mar